guidance.fyi
Company, ticker, metric, guidance, or anything said
VerifiedNumbers checked and claims independently audited

Q1 FY27 concall · earnings callGujarat Fluorochemicals Limited

GFL delivered strong broad-based growth in its core chemical segments, with fluorochemicals and fluoropolymers driving significant revenue and profit increases, while battery materials commercialization and key capacity expansions are on track to fuel future growth.

Positive tone4-minute briefPublished 7 days after the call

Numbers
MetricThis quarterChangeFive-quarter trend
Consolidated Revenue₹1,588 Cr24%
Consolidated PAT₹219 Cr19%
Consolidated EBITDA₹428 Cr24%
Chemical Segment Revenue₹1,574 Cr23%
Chemical Segment PAT₹261 Cr33%
ROCE16.6%258 bps
Financials

From filed quarterly results. YoY and QoQ compare each metric on the same accounting basis.

QuarterRevenueNet profit (PAT)Basic EPS
Q3 FY25₹1,148.00 Cr+15.8% YoY-3.4% QoQ₹126.00 Cr+57.3% YoY+4.1% QoQ₹11.47+57.3% YoY+4.4% QoQ
Q2 FY25₹1,188.00 Cr+25.5% YoY+1% QoQ₹121.00 Cr+129.4% YoY+12% QoQ₹10.99+129% YoY+12% QoQ
Q1 FY25₹1,176.00 Cr-2.8% YoY+3.8% QoQ₹108.00 Cr-46.3% YoY+7% QoQ₹9.81-46.4% YoY+6.7% QoQ
Q4 FY24₹1,133.03 Cr-23% YoY+14.2% QoQ₹100.97 Cr-69.6% YoY+26.1% QoQ₹9.19-69.6% YoY+26.1% QoQ
Q3 FY24₹991.74 Cr-30.1% YoY+4.7% QoQ₹80.09 Cr-75.8% YoY+51.9% QoQ₹7.29-75.8% YoY+51.9% QoQ
TL;DR
  • Consolidated revenue grew 24% YoY to INR 1,588 crores, with PAT up 19% to INR 219 crores.
  • Sequential performance was even stronger, with consolidated PAT more than doubling and margins expanding.
  • Fluorochemical revenue surged 52% YoY, driven by R32 refrigerant sales; R32 capacity expansion expected in Q2 FY27.
  • Fluoropolymer revenue grew 15% YoY, driven by higher-value grades and new-age applications.
  • Battery materials segment is progressing; significant revenue ramp-up expected by end of FY27 and into FY28.
  • Working capital days improved by 43 days, and ROCE/ROE metrics showed significant year-on-year improvement.
Said on the call

“Fluoropolymers has done well and expected to grow, as we had said earlier, 17% to 20% annually going forward as well, again, primarily on volume as well as the high-value products.”

Bir Kapoor, CEO and Deputy Managing Director
From the Q&A
TopicWhat management said
Fluoropolymer Pricing & CompetitionManagement stated growth is driven by moving up the value chain into specialty products, not competing directly on price with Chinese players; there have been marginal price increases to cover input costs, with more impact expected in subsequent quarters.
R134A Refrigerant ProjectThe R134A project is on track for commissioning within FY27; it is a brownfield expansion, and TCE raw material will be imported, not backward integrated. The capacity size has not been announced.
Battery Materials Revenue Ramp-upManagement expects significant traction towards the end of FY27 and into FY28, with a target for '3 digit' revenue by Q4 FY27. The ramp-up will follow a long qualification process, with LiPF6 leading, followed by PVDF and LFP.
Oman Project ShiftThe battery materials project in Oman has been put on hold and shifted to India due to geopolitical delays and a more attractive domestic market; associated funding from OIA is also on hold.
Fluoropolymer Capacity & GrowthGrowth will come from new high-end fluoropolymers for semiconductors, data centers, and green hydrogen, with debottlenecking ongoing. The 17-20% annual growth target is confirmed as 'absolutely visible.'
R32 Capacity & QuotasExisting R32 capacity is fully utilized; additional capacity is expected in Q2 FY27. Management expects full utilization of the expanded capacity. Quota entitlement is based on production capacity and GWP, not consumption.
Guidance
  • R32 capacity expansion is expected to be commissioned in Q2 FY27.
  • R134A project is expected to be commissioned during FY27.
  • Battery materials segment is expected to see significant revenue traction by the end of FY27 and a ramp-up in FY28.
  • Fluoropolymer business is expected to grow 17% to 20% annually going forward.
  • Capex plan for FY27 includes INR 2,300 crores for the EV (battery materials) segment and approximately INR 800 crores for the chemical business.
Source
Same sector

Others in Chemicals

All Chemicals →
  • Prasol Chemicals LimitedQ1 FY27Positive tone

    Q1 FY27 was exceptionally strong on inventory gains from West Asia-led acetone price rises, while underlying mid-single-digit volume growth remained healthy and management guided for INR1,550 crores to INR1,650 crores revenue in FY27 with normalization of margins ahead.

    Revenue from operations - Q1 FY27
    ₹433.6 Cra growth of 35.7% YoY
    Gross margin - Q1 FY27
    37.9%compared to 30% in Q1 FY26
    PRASOLCHEMChemicalsVerified brief5 guidance items
  • Solar Industries India LimitedQ1 FY27Positive tone

    Solar Industries agreed to acquire South Africa's Omnia Holdings for cash funded by debt and internal accruals to build an integrated global explosives and blasting solutions platform with backward integration into ammonium nitrate.

    Solar projected current year revenue
    ₹14,000 Cr
    Solar projected FY28 revenue
    ₹16,500 Cr
    SOLARINDSChemicalsVerified brief4 guidance items
  • Indo Borax & Chemicals LimitedQ1 FY27Positive tone

    Q1 FY27 delivered 31.34% revenue growth and 59.31% profit growth from better utilization and realizations while Indo Borax moved to acquire 64.26% of Kronox Lab Sciences.

    Operating revenue
    ₹70.36 Cr+31.34% increase against ₹53.57 Cr in Q1 FY 26
    EBITDA
    ₹19.8 Crup by 62.16% vs ₹12.21 Cr in Q1 FY 26
    INDOBORAXChemicalsVerified brief5 guidance items
  • Stallion India started FY27 with strong profit growth and is focusing on executing key expansion projects, including its high-purity helium and R32 manufacturing facilities, to drive future growth.

    Total Revenue
    124.68 crores12.78%
    EBITDA
    25.27 crore75.85%
    STALLIONChemicalsVerified brief4 guidance items
  • Ester Industries LimitedQ1 FY27Positive tone

    The quarter was driven by a strong rebound in the BOPET film business due to improved industry pricing and capacity utilization, leading to a significant turnaround in consolidated profitability.

    Consolidated Total Income
    ₹441.9 Cr27.4%
    Consolidated EBITDA
    ₹58.9 Cr103.4%
    ESTERChemicalsVerified brief4 guidance items